Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-01
DOI
10.3389/fonc.2019.01155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of surgery and radiation in advanced gastric cancer: A population-based study of Surveillance, Epidemiology, and End Results database
- (2019) Shuang Ye et al. PLoS One
- Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
- (2018) Hironori Ishigami et al. JOURNAL OF CLINICAL ONCOLOGY
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
- (2018) Hongmei Zeng et al. Lancet Global Health
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
- (2018) K Muro et al. ANNALS OF ONCOLOGY
- Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
- (2018) Seung-Hoon Beom et al. BMC CANCER
- The 30-year experience—A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer
- (2017) Jacopo Desiderio et al. EUROPEAN JOURNAL OF CANCER
- Influence of Surgical Resection of Hepatic Metastases From Gastric Adenocarcinoma on Long-term Survival
- (2016) Sheraz R. Markar et al. ANNALS OF SURGERY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care
- (2016) Paul H. Sugarbaker CANCER TREATMENT REVIEWS
- Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis
- (2016) F. Coccolini et al. EJSO
- A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent
- (2016) Y. Yonemura et al. EJSO
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)
- (2016) Gastric Cancer
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2016) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent strategies for treating stage IV gastric cancer: roles of palliative gastrectomy, chemotherapy, and radiotherapy
- (2016) Journal of Gastrointestinal and Liver Diseases
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- REGATTA trial: a call for the USA and Europe
- (2016) Domenico D'Ugo et al. LANCET ONCOLOGY
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
- (2016) Kazumasa Fujitani et al. LANCET ONCOLOGY
- Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis
- (2015) Sabrina M. Ebinger et al. Gastric Cancer
- A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis
- (2014) Yan Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor
- (2014) Jang Ho Cho et al. Cancer Research and Treatment
- Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials
- (2013) F. Coccolini et al. EJSO
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Management of gastric cancer in Asia: resource-stratified guidelines
- (2013) Lin Shen et al. LANCET ONCOLOGY
- Multidisciplinary Management of Gastric Cancer
- (2013) Jamal G. Misleh et al. Surgical Oncology Clinics of North America
- Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone
- (2012) Jung Hun Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
- (2011) Peter C. Thuss-Patience et al. EUROPEAN JOURNAL OF CANCER
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
- (2010) Ilfet Songun et al. LANCET ONCOLOGY
- Is there a role for second-line chemotherapy in advanced gastric cancer?
- (2009) Robert Wesolowski et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started